Dr. Andrew Carlson, MD
Claim this profileUniversity of New Mexico Hospital
Affiliated Hospitals
University Of New Mexico Hospital
University Of New Mexico
Clinical Trials Andrew Carlson, MD is currently running
MW189
for Brain Bleed
This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).
Recruiting
0 awards
Phase 2
11 criteria
Multimodal Therapy
for Brain AVM
The objectives of this study and registry are to offer the best management possible for patients with brain arteriovenous malformations (AVMs) (ruptured or unruptured) in terms of long-term outcomes, despite the presence of uncertainty. Management may include interventional therapy (with endovascular procedures, neurosurgery, or radiotherapy, alone or in combination) or conservative management. The trial has been designed to test a) whether medical management or interventional therapy will reduce the risk of death or debilitating stroke (due to hemorrhage or infarction) by an absolute magnitude of about 15% (over 10 years) for unruptured AVMs (from 30% to 15%); and, b) to test if endovascular treatment can improve the safety and efficacy of surgery or radiation therapy by at least 10% (80% to 90%). As for the nested trial on the role of embolization in the treatment of Brain AVMs by other means: the pre-surgical or pre-radiosurgery embolization of cerebral AVMs can decrease the number of treatment failures from 20% to 10%. In addition,embolization of cerebral AVMs can be accomplished with an acceptable risk, defined as permanent disabling neurological complications of 8%.
Recruiting
1 award
N/A
1 criteria
More about Andrew Carlson, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Andrew Carlson, MD has experience with
- Programmable CSF Shunt Valve
- MW189
- Embolization
- Neurosurgery
- Radiation Therapy
Breakdown of trials Andrew Carlson, MD has run
Normal Pressure Hydrocephalus
Neuroinflammatory Disease
Brain Edema
Posterior Fossa Hemorrhage
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Carlson, MD specialize in?
Andrew Carlson, MD focuses on Stroke and Normal Pressure Hydrocephalus. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Andrew Carlson, MD currently recruiting for clinical trials?
Yes, Andrew Carlson, MD is currently recruiting for 2 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Andrew Carlson, MD has studied deeply?
Yes, Andrew Carlson, MD has studied treatments such as Programmable CSF Shunt Valve, MW189, Embolization.
What is the best way to schedule an appointment with Andrew Carlson, MD?
Apply for one of the trials that Andrew Carlson, MD is conducting.
What is the office address of Andrew Carlson, MD?
The office of Andrew Carlson, MD is located at: University of New Mexico Hospital, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.